Plaque mOrphology iMpact on Side Branch Occlusion at oPtical Coherence Tomography Evaluation in Percutaneous Coronary Interventions

NCT ID: NCT04501549

Last Updated: 2020-08-06

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 27 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2018-07-23
• Study Completion Date: 2021-04-14

Brief Summary

Despite recent advances in interventional cardiology, bifurcation coronary artery stenoses (which account for 15-20% of all coronary lesions treated by PCI), remain a challenge for PCI operators with higher rates of failure, in-stent restenosis, stent thrombosis, and recurrent clinical events, when compared to simple non-bifurcation lesions.

POMPEI trial is a prospective observational study. We aim to investigate the impact of morphological plaque characteristics assessed by optical coherence tomography (OCT) on the risk of developing side branch occlusion (SBO) in bifurcation PCI.

A total of 27 patients undergoing bifurcation PCI will be recruited into the trial. PCI will be performed according to local practice.The bifurcation lesion will be imaged by OCT on at least two time-points for each patient. Plaque morphology will be characterized by OCT. Off-line quantitative coronary angiography (QCA) will be performed before and after PCI and the following QCA parameters will be computed: reference vessel diameter (RVD), lesion length and diameter stenosis (DS) of Main Vessel (MV) and side branch (SB). Blood samples will be taken prior to PCI and 8-12 hours later to determine peri-procedural myocardial injury and infarction following PCI by measuring serum Troponin. The OCT data analysis will be performed in collaboration with Dr Valeria Paradies who has been trained in interventional cardiology in Rotterdam (The Netherlands) with specific interest in intravascular imaging.

In conclusion, we will use OCT to detect specific morphological characteristics which are associated with acute SBO following main vessel stenting. The routine use of OCT during bifurcation PCI to detect those patients at risk of acute SBO following main vessel stenting will allow the PCI operator to implement measures for reducing the risk of SBO, thereby minimizing the risk of peri- and post-PCI angina, preventing peri-procedural myocardial injury and infarction, and improving clinical outcomes.

Detailed Description

We hypothesized that in bifurcation lesion treatment, morphology of the plaque located in the main vessel may impact on the risk of developing SBO.

The objectives of POMPEI study as follows:

Primary objective:

To identify correlation between lipid volume content of MV plaque and risk of SBO (TIMI flow<3)

Secondary objectives:

To identify the plaque morphology characteristics associated with SBO in patients undergoing bifurcation PCI. OCT parameters which will be assessed include: distribution of lipid volume and lipid arc in the MV and around SB ostium before and after stenting; prevalence of healed plaque rupture and erosion and its correlation with SBO; correlation between calcium distribution within the plaque and SBO; correlation between bifurcation angle and SBO; and correlation between angiographic images of haziness at SB ostium and OCT findings.

To determine the prevalence of significant SB ostium stenosis in patients undergoing bifurcation PCI.

To determine the incidences of SBO following bifurcation PCI.

To determine the incidence and extent of peri-procedural myocardial injury and infarction following bifurcation PCI.

To determine correlation between SB lesion extension from the ostium and SBO

Conditions

Bifurcation; Percutaneous Coronary Intervention

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: PROSPECTIVE

Interventions

percutaneous coronary intervention

PCI will be performed according to local practice.The bifurcation lesion will be imaged by OCT on at least two time-points for each patient. Plaque morphology will be characterized by OCT. Off-line quantitative coronary angiography (QCA) will be performed before and after PCI and the following QCA parameters will be computed: reference vessel diameter (RVD), lesion length and diameter stenosis (DS) of Main Vessel (MV) and side branch (SB). Blood samples will be taken prior to PCI and 8-12 hours later to determine peri-procedural myocardial injury and infarction following PCI by measuring serum Troponin.

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Age≥21 years of age
• Able to provide consent
• At least one de-novo bifurcation lesion involving a side-branch (SB) ≥ 2mm and SB ostial lesion ≥50% and <90% by visual assessment intended to be treated by PCI with provisional stenting strategy
• TIMI flow 3 in both MV and SB

Exclusion Criteria

• Previous PCI of the target vessel
• Cardiac arrest or cardiogenic shock
• Left main or saphenous venous graft bifurcation
• Significant renal impairment patients (eGFR<30) who are not on dialysis
• Inability to advance the OCT catheter or to obtain good image quality

• Minimum Eligible Age: 21 Years
• Maximum Eligible Age: 99 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Heart Centre Singapore

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Chin Chee Yang, MD

Role: PRINCIPAL_INVESTIGATOR

National Heart Centre Singapore

Locations

National Heart Centre Singapore

Singapore, , Singapore

Site Status: RECRUITING

Countries

Singapore

Central Contacts

VANESSA WAN

Role: CONTACT

vanessa.wan@nhcs.com.sg

+6567062273

Facility Contacts

Vanessa Wan

Role: primary

vanessa.wan@nhcs.com.sg

+6567042273

Other Identifiers

2018/2493

Identifier Type: -

Identifier Source: org_study_id